Investors & Dealmaking
The Digest: April 2026
In this month's news, mixed results for clinical trials, Merit Medical continues its buying streak with View Point Medical, six FDA clearances, and more.
Read ArticleColin Miller
Contributing Writer
5 Years of Experience
About
Colin Miller is a staff writer and medtech analyst. Colin focuses on emerging and disruptive medical device technologies within vast therapeutic areas such as women’s health, wound care, neurovascular, critical care, surgical robotics and cardiovascular. Colin attended McGill University in Montreal and graduated from the University of Minnesota.